Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair

A newly unsealed whistleblower lawsuit accuses Novartis and Genentech of being at the center of a decades-long kickback scheme to promote their immunology med Xolair across dozens of states. | The newly unsealed lawsuit highlights potential False Claims Act violations and comes from five whistleblowers who previously worked on Xolair promotion at the companies.